•  
News
  1. Healio
  2. Hematology/Oncology
  3. Hematology Oncology

HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

April 10, 2019
Table of Contents
Cover Story

Advances in chronic lymphocytic leukemia suggest progress is ‘visible on the horizon’

Point/Counter

Is ibrutinib-based therapy the preferred initial treatment for all patients with CLL?

Editorial

The potential benefits (and pitfalls) of real-world evidence in oncology

John Sweetenham, MD

Commentary

Immunotherapy for head and neck cancer an evolving paradigm

Charu Aggarwal, MD, MPH

Treatment response in AML: Understanding available molecular diagnostic data

David F. Claxton, MD; Megan Wheelden, MD

Meeting News

Penile squamous cell carcinoma may benefit from therapies used in HPV-related cancers

Researchers identify genomic drivers of poor survival, enzalutamide resistance in advanced prostate cancer

Colorectal cancer in young patients often misdiagnosed, identified at late stage

Lung cancer ‘personifies precision medicine’

Genetic testing can detect melanoma earlier, but tailored approach is required

Alpelisib prolongs PFS in breast cancer subset

Preoperative breast MRI valuable complement to mammography, ultrasound

Daratumumab regimen yields durable responses in relapsed, refractory multiple myeloma

Hydroxyurea benefits children from sub-Sahara Africa with sickle cell anemia

FDA News

Pembrolizumab granted priority review for three oncology indications

FDA expands Sprycel approval to include certain children with acute lymphoblastic leukemia

$name

FDA News

FDA approves subcutaneous Herceptin Hylecta for HER2-positive breast cancer